Preview
The ultrasensitive third-generation assay for thyrotropin (TSH) is now the “gold standard” for measuring thyroid activity. Who should be screened with it, and what further studies should be done if results are abnormal? Which patients with subclinical disease should receive treatment? Drs Brody and Reichard discuss these and other issues and provide an algorithm for thyroid screening.
Additional information
Notes on contributors
Marion B. Brody
Marion B. Brody, MD Rita A. Reichard, MD Drs Brody and Reichard are assistant professors of medicine, division of general internal medicine, department of medicine, Temple University Hospital, Philadelphia.
Rita A. Reichard
Marion B. Brody, MD Rita A. Reichard, MD Drs Brody and Reichard are assistant professors of medicine, division of general internal medicine, department of medicine, Temple University Hospital, Philadelphia.